BR9907283A - Vìrus do herpes simples, uso de um vìrus do herpes simples, composição farmacêutica, e, processos para estudar a função de gene heterólogo em uma célula de mamìfero e para produzir um vìrus do herpes simples - Google Patents
Vìrus do herpes simples, uso de um vìrus do herpes simples, composição farmacêutica, e, processos para estudar a função de gene heterólogo em uma célula de mamìfero e para produzir um vìrus do herpes simplesInfo
- Publication number
- BR9907283A BR9907283A BR9907283-1A BR9907283A BR9907283A BR 9907283 A BR9907283 A BR 9907283A BR 9907283 A BR9907283 A BR 9907283A BR 9907283 A BR9907283 A BR 9907283A
- Authority
- BR
- Brazil
- Prior art keywords
- herpes simplex
- simplex virus
- gene
- study
- processes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
"VìRUS DO HERPES SIMPLES, USO DE UM VìRUS DO HERPES SIMPLES, COMPOSIçãO FARMACêUTICA, E, PROCESSOS PARA ESTUDAR A FUNçãO DE UM GENE HETERóLOGO EM UMA CéLULA DE MAMìFERO E PARA PRODUZIR UM VìRUS DO HERPES SIMPLES". A presente invenção proporciona uma cepa de vírus do herpes simples possuindo um gene ICP27 funcional e faltante de pelo menos um gene ICP4 funcional e um gene ICP34.5 funcional. Também proporciona o uso de uma cepa de vírus do herpes simples que é faltante de pelo menos um gene ICP4 funcional e um gene ICP34.5 funcional no tratamento de distúrbios do, ou de lesões no, sistema nervoso de um mamífero.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9801930.0A GB9801930D0 (en) | 1998-01-29 | 1998-01-29 | Mutant herpes simplex viruses and uses thereof |
PCT/GB1999/000306 WO1999038955A2 (en) | 1998-01-29 | 1999-01-29 | Mutant herpes simplex viruses and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9907283A true BR9907283A (pt) | 2000-10-24 |
Family
ID=10826120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9907283-1A BR9907283A (pt) | 1998-01-29 | 1999-01-29 | Vìrus do herpes simples, uso de um vìrus do herpes simples, composição farmacêutica, e, processos para estudar a função de gene heterólogo em uma célula de mamìfero e para produzir um vìrus do herpes simples |
Country Status (12)
Country | Link |
---|---|
US (1) | US6719982B1 (pt) |
EP (1) | EP1049769A2 (pt) |
JP (1) | JP2002501742A (pt) |
KR (1) | KR20010040430A (pt) |
CN (1) | CN1295612A (pt) |
AU (1) | AU749017B2 (pt) |
BR (1) | BR9907283A (pt) |
CA (1) | CA2319669A1 (pt) |
GB (2) | GB9801930D0 (pt) |
HK (1) | HK1035378A1 (pt) |
IL (1) | IL137531A0 (pt) |
WO (1) | WO1999038955A2 (pt) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9801930D0 (en) | 1998-01-29 | 1998-03-25 | Univ London | Mutant herpes simplex viruses and uses thereof |
GB0009079D0 (en) * | 2000-04-12 | 2000-05-31 | Neurovex Ltd | Herpes viruses for immune modulation |
GB9930418D0 (en) | 1999-12-22 | 2000-02-16 | Neurovex Ltd | Replication incompetent herpes virus vectors |
GB9930419D0 (en) * | 1999-12-22 | 2000-02-16 | Neurovex Ltd | Replication incompetent herpes virus vectors |
DE60107203T3 (de) | 2000-01-21 | 2009-07-23 | Biovex Ltd. | Herpes-virusstämme für die gentherapie |
US20040229362A1 (en) * | 2003-05-15 | 2004-11-18 | Alberto Epstein | Method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding genetic tools, as well as the applications of these non-pathogenic amplicon vectors |
GB0317511D0 (en) * | 2003-07-25 | 2003-08-27 | Biovex Ltd | Viral vectors |
WO2005049846A2 (en) | 2003-11-17 | 2005-06-02 | Crusade Laboratories Limited | Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer |
GB0326798D0 (en) * | 2003-11-17 | 2003-12-24 | Crusade Lab Ltd | Methods for generating mutant virus |
US7897146B2 (en) | 2003-11-17 | 2011-03-01 | Crusade Laboratories Limited | Treatment using herpes simplex virus |
EP1732614B1 (en) * | 2004-04-08 | 2008-12-24 | Sangamo Biosciences Inc. | Compositions for treating neuropathic and neurodegenerative conditions |
GB0408103D0 (en) * | 2004-04-08 | 2004-05-12 | Crusade Lab Ltd | Novel herpes simplex viruses |
US20060023160A1 (en) * | 2004-08-02 | 2006-02-02 | Cartier Jon P | Lens structure and method of making the same |
WO2007016239A2 (en) * | 2005-07-29 | 2007-02-08 | President And Fellows Of Harvard College | Herpes simplex virus mutant and uses therefore |
EP3022307A4 (en) * | 2013-07-17 | 2017-04-19 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Non-toxic hsv vectors for efficient gene delivery applications and complementing cells for their production |
CN105219738A (zh) * | 2015-09-21 | 2016-01-06 | 北京神源德生物科技有限公司 | 重组单纯疱疹病毒及它感染和制备它的宿主细胞以及它们的应用 |
CN105219739A (zh) * | 2015-09-21 | 2016-01-06 | 北京神源德生物科技有限公司 | 重组单纯疱疹病毒及它感染和制备它的宿主细胞以及它们的应用 |
US9877990B2 (en) * | 2016-04-08 | 2018-01-30 | Krystal Biotech, Inc. | Compositions and methods for the treatment of wounds, disorders, and diseases of the skin |
KR20190006495A (ko) | 2016-04-15 | 2019-01-18 | 알파인 이뮨 사이언시즈, 인코포레이티드 | Cd80 변이체 면역조절 단백질 및 그의 용도 |
KR20230051602A (ko) | 2016-04-15 | 2023-04-18 | 알파인 이뮨 사이언시즈, 인코포레이티드 | Icos 리간드 변이체 면역조절 단백질 및 그의 용도 |
WO2017181420A1 (en) * | 2016-04-22 | 2017-10-26 | Immuno Vir Co., Limited | CONSTRUCTION OF ONCOLYTIC HERPES SIMPLEX VIRUSES (oHSV) OBLIGATE VECTOR AND CONSTRUCTS FOR CANCER THERAPY |
WO2018022945A1 (en) | 2016-07-28 | 2018-02-01 | Alpine Immune Sciences, Inc. | Cd112 variant immunomodulatory proteins and uses thereof |
CN110088127A (zh) | 2016-07-28 | 2019-08-02 | 高山免疫科学股份有限公司 | Cd155变体免疫调节蛋白及其用途 |
US11471488B2 (en) | 2016-07-28 | 2022-10-18 | Alpine Immune Sciences, Inc. | CD155 variant immunomodulatory proteins and uses thereof |
CN106318915B (zh) * | 2016-09-21 | 2020-02-18 | 重庆宇珩生物科技有限公司 | 重组单纯疱疹病毒HSV-hTERTp_ICP4_LungCA-GFP及诊断试剂盒 |
AU2017345764A1 (en) | 2016-10-20 | 2019-05-02 | Alpine Immune Sciences, Inc. | Secretable variant immunomodulatory proteins and engineered cell therapy |
CN110546265A (zh) | 2017-02-09 | 2019-12-06 | 因达普塔治疗公司 | 工程化自然杀伤(nk)细胞及其组合物和方法 |
EP3596116B1 (en) | 2017-03-16 | 2023-09-06 | Alpine Immune Sciences, Inc. | Pd-l1 variant immunomodulatory proteins and uses thereof |
US11732022B2 (en) | 2017-03-16 | 2023-08-22 | Alpine Immune Sciences, Inc. | PD-L2 variant immunomodulatory proteins and uses thereof |
AU2018235838B2 (en) | 2017-03-16 | 2023-12-14 | Alpine Immune Sciences, Inc. | CD80 variant immunomodulatory proteins and uses thereof |
EP3694870A1 (en) | 2017-10-10 | 2020-08-19 | Alpine Immune Sciences, Inc. | Ctla-4 variant immunomodulatory proteins and uses thereof |
EA202090974A1 (ru) | 2017-10-18 | 2020-08-05 | Элпайн Иммьюн Сайенсиз, Инк. | Вариантные иммуномодулирующие белки лиганда icos и сопутствующие композиции и способы |
SG11202006148UA (en) | 2018-01-03 | 2020-07-29 | Alpine Immune Sciences Inc | Multi-domain immunomodulatory proteins and methods of use thereof |
AU2019252658B2 (en) | 2018-04-12 | 2023-09-14 | Krystal Biotech, Inc. | Compositions and methods for the treatment of autosomal recessive congenital ichthyosis |
AU2019260757B2 (en) | 2018-04-27 | 2023-09-28 | Krystal Biotech, Inc. | Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic applications |
WO2019241758A1 (en) | 2018-06-15 | 2019-12-19 | Alpine Immune Sciences, Inc. | Pd-1 variant immunomodulatory proteins and uses thereof |
EP3856761A1 (en) | 2018-09-24 | 2021-08-04 | Krystal Biotech, Inc. | Compositions and methods for the treatment of netherton syndrome |
KR20210123289A (ko) | 2018-11-21 | 2021-10-13 | 인답타 세라뷰틱스 인코포레이티드 | 자연 살해 세포 서브세트의 증식을 위한 방법 및 관련 조성물 및 방법 |
JP2022510276A (ja) | 2018-11-30 | 2022-01-26 | アルパイン イミューン サイエンシズ インコーポレイテッド | Cd86バリアント免疫調節タンパク質およびその使用 |
CN113454105A (zh) | 2019-02-08 | 2021-09-28 | 克里斯托生物技术股份有限公司 | 用于递送cftr多肽的组合物和方法 |
JP2023523429A (ja) | 2020-04-22 | 2023-06-05 | インダプタ セラピューティクス インコーポレイテッド | ナチュラルキラー(nk)細胞組成物およびそれを生成させるための方法 |
WO2022170219A1 (en) | 2021-02-05 | 2022-08-11 | Iovance Biotherapeutics, Inc. | Adjuvant therapy for cancer |
EP4314028A1 (en) | 2021-04-02 | 2024-02-07 | Krystal Biotech, Inc. | Viral vectors for cancer therapy |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5665362A (en) * | 1990-09-25 | 1997-09-09 | Cantab Pharmaceuticals Research Limited | Viral vaccines |
US6010908A (en) * | 1992-08-21 | 2000-01-04 | The Regents Of The University Of California | Gene therapy by small fragment homologous replacement |
US5658724A (en) * | 1992-07-31 | 1997-08-19 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains deficient for the essential immediate early genes ICP4 and ICP27 and methods for their production, growth and use |
AU6964596A (en) | 1995-09-11 | 1997-04-01 | Arch Development Corporation | Materials and methods for treating neurodegenerative diseases and for screening for candidate apoptosis inhibitors and inducers |
GB9615794D0 (en) * | 1996-07-26 | 1996-09-04 | Medical Res Council | Mutant herpes simplex virus strains and uses thereof |
GB9700411D0 (en) | 1997-01-10 | 1997-02-26 | Univ London | Eukaryotic gene expression cassette and uses thereof |
GB9801930D0 (en) | 1998-01-29 | 1998-03-25 | Univ London | Mutant herpes simplex viruses and uses thereof |
-
1998
- 1998-01-29 GB GBGB9801930.0A patent/GB9801930D0/en not_active Ceased
-
1999
- 1999-01-29 GB GB0020940A patent/GB2353529B/en not_active Expired - Fee Related
- 1999-01-29 CA CA002319669A patent/CA2319669A1/en not_active Abandoned
- 1999-01-29 IL IL13753199A patent/IL137531A0/xx unknown
- 1999-01-29 WO PCT/GB1999/000306 patent/WO1999038955A2/en not_active Application Discontinuation
- 1999-01-29 BR BR9907283-1A patent/BR9907283A/pt not_active IP Right Cessation
- 1999-01-29 KR KR1020007008214A patent/KR20010040430A/ko not_active Application Discontinuation
- 1999-01-29 AU AU22911/99A patent/AU749017B2/en not_active Ceased
- 1999-01-29 EP EP99902699A patent/EP1049769A2/en not_active Withdrawn
- 1999-01-29 JP JP2000529416A patent/JP2002501742A/ja active Pending
- 1999-01-29 CN CN99804601A patent/CN1295612A/zh active Pending
- 1999-01-29 US US09/601,102 patent/US6719982B1/en not_active Expired - Fee Related
-
2001
- 2001-08-08 HK HK01105499A patent/HK1035378A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB9801930D0 (en) | 1998-03-25 |
US6719982B1 (en) | 2004-04-13 |
EP1049769A2 (en) | 2000-11-08 |
JP2002501742A (ja) | 2002-01-22 |
GB0020940D0 (en) | 2000-10-11 |
HK1035378A1 (en) | 2001-11-23 |
CN1295612A (zh) | 2001-05-16 |
CA2319669A1 (en) | 1999-08-05 |
GB2353529A (en) | 2001-02-28 |
WO1999038955A3 (en) | 1999-09-23 |
GB2353529B (en) | 2003-01-15 |
AU2291199A (en) | 1999-08-16 |
IL137531A0 (en) | 2001-07-24 |
AU749017B2 (en) | 2002-06-13 |
WO1999038955A2 (en) | 1999-08-05 |
KR20010040430A (ko) | 2001-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9907283A (pt) | Vìrus do herpes simples, uso de um vìrus do herpes simples, composição farmacêutica, e, processos para estudar a função de gene heterólogo em uma célula de mamìfero e para produzir um vìrus do herpes simples | |
BRPI0107737B8 (pt) | vírus do herpes simplex 1 (hsv1), uso do hsv1, e, composição farmacêutica | |
DE69725452D1 (de) | Hsv stamm mit mangel für funktionelle icp27 und icp34.5 genen | |
BR9802509A (pt) | Uso de um copolímero tendo estrutura sufactante ou tensoativa como agente dispersante e/ou auxiliar de moagem. | |
DE69332525T2 (de) | Behandlung von Tumorerkrankungen mit modifiziertem HSV | |
CA2342582A1 (en) | A method of inhibiting formation of infectious herpes virus particles | |
BR9914606A (pt) | Uso de fumaratos de dialquila | |
BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
MY141641A (en) | Compositions comprising viruses and methods for concentrating virus preparations | |
WO1999053958A3 (en) | Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor | |
BR0015416A (pt) | Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos | |
BR9808606A (pt) | Materiais e métodos para tratamento de doenças com ribozimas | |
BR0211008A (pt) | Combinação de ingrediente ativo, uso de uma combinação de ingrediente ativo e método para a terapia farmacológia de uma substância que causa dependência ou que seja intoxicante | |
BR9815276A (pt) | Concentrado de filtro solar à prova d'água na forma de uma dispersão uniforme e estável | |
BR0110208A (pt) | Composições e terapias para distúrbios associados com hiperlipidemia | |
NZ505834A (en) | Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use | |
BR9910594A (pt) | Vìrus de herpes simplex, uso de um vìrus de herpessimplex, composição farmacêutica e processospara estudar a função de um gene heterólogo emuma célula de mamìfero, para produzir um vìrus deherpes simplex e para tratar um distúrbio ou uma lesãodo sistema nervoso de um mamìfero | |
ES2141093T3 (es) | Herpesvirus equinos (ehv) que contienen adn ajeno, procedimiento para su obtencion y su empleo en vacunas. | |
BR0016419A (pt) | Método para o aumento das respostas de imunização com relação a vacina do vìrus do herpes simplex | |
ATE272713T1 (de) | Ehv-1 vektoren | |
NO892125L (no) | Kombinasjon av angiotensin-omvandlende-enzymhemmere med kaliumkanal-modulatorer samt deres anvendelse i legemidler. | |
BR9908443A (pt) | Linhagens de células de medula espinhal humana e métodos para uso das mesmas | |
BR9811963A (pt) | Uso de 17-alfa-estradiol para o tratamento de pele envelhecida ou danificada pelo sol e/ou atrofia de pele | |
ATE417926T1 (de) | Zusammensetzungen zur modulierung der länge von telomeren | |
CR6302A (es) | Nuevos usos farmaceuticos par inhibidores nos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TE | Change of address | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |